Skip to main content
SpringerLink
Log in

Abnormal nevi, excess total nevi, and melanoma: an epidemiologic perspective

  • Chapter
Malignant Melanoma: Biology, Diagnosis, and Therapy

Part of the book series: Cancer Treatment and Research ((CTAR,volume 43))

Abstract

... evolution of a cancer involves more than loss of growth controls and rapid proliferation; it may also represent a disorder of differentiation, maturation and death of cells. [1]

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Robbins SL, Cotran RS, Kumar V: Pathologic basis of disease. Philadelphia: WB Saunders, 1984, p. 222.

    Google Scholar 

  2. Nordlund JJ, Kirkwood J, Forget BM, et al: Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 45:1855–1861, 1985.

    PubMed  CAS  Google Scholar 

  3. Roush GC, Titus LJ, Ernstoff MS, et al: Pigmentary risk factors for biopsy proven dysplastic nevi in determining risk for melanoma (abstract C77). Proc Am Soc Clinical Oncology 4:20, 1985.

    Google Scholar 

  4. Roush GC, McKay L, Nordlund J, et al: Dependence of total nevi on dysplastic nevi determining risk for melanoma. Prev Med 15:699–707, 1986.

    Article  Google Scholar 

  5. Holman DCJ, Armstrong BK: Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Nat Cancer Inst 72:257–266, 1984.

    PubMed  CAS  Google Scholar 

  6. Green A, Bain C, McLennan R, et al: Risk factors for cutaneous melanoma in Queensland. Recent Res Cancer Res 102:76–97, 1986.

    CAS  Google Scholar 

  7. Swerdlow AJ, Enlish J, MacKie RM, et al: Benign melanocytic nevi as a risk factor for malignant melanoma. Br J Cancer 292:1555–1559, 1986.

    CAS  Google Scholar 

  8. Elwood JM, Williamson C, Stapleton PJ: Malignant melanoma in relation to moles, pigmentation and exposure to fluorescent and other lighting sources. Br J Cancer 53:74, 1986.

    Article  Google Scholar 

  9. Holly EA, Shpall SN, Schneider J, et al: Total body nevi counts and other risk factors for malignant melanoma (abstract). Prev Med 15:705, 1986.

    Google Scholar 

  10. Dubin N, Moseson M, Pasternak BS: Epidemiology of malignant melanoma: Pigmentary traits, ultraviolet radiation, and identification of high risk populations. Rec Res Ca Res 102:56–75, 1986.

    CAS  Google Scholar 

  11. Rhodes AR, Sober AJ, Mihm MC, et al: Possible risk factor for primary cutaneous malignant melanoma (abstract). Clinical Res 28:252A, 1980.

    Google Scholar 

  12. Rhodes AR: The risk of malignant melanoma arising in congenital melanocytic nevi: An argument against the assignment of risk based on size alone. Am J Dermatopathol 6 (suppl 1):184–188, 1984.

    PubMed  Google Scholar 

  13. Mark GL, Mihm MC, Litelpo MG, et al: Congenital melanocytic nevi of the small and garment type: Clinical, histopathologic, and ultrastructural studies. Hum Path 4:395–418, 1973.

    Article  PubMed  CAS  Google Scholar 

  14. Rhodes AR, Sober AJ, Day CL, et al: The malignant potential of small congenital nevocellular nevi. J Am Acad Derm 6:230–241, 1982.

    Article  PubMed  CAS  Google Scholar 

  15. Rhodes AR: Pigmented birthmarks and precursor melanocytic lesions of cutaneous melanoma identifiable in childhood. Pedia Clinics NA 30:435–463, 1983.

    CAS  Google Scholar 

  16. Rhodes AR: Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management. Med Clinics NA 70:3–38, 1986.

    CAS  Google Scholar 

  17. Walton RG, Jacobs AH, Cox AJ: Pigmented lesions in newborn infants. Br J Dermatol 95:389–396, 1976.

    Article  PubMed  CAS  Google Scholar 

  18. Skov-Jensen T, Hastrup J, Lambrethsen E: Malignant melanoma in children. Cancer 19:620–626, 1966.

    Article  PubMed  CAS  Google Scholar 

  19. Trozak DJ, Rowland WD, Hu F: Metastatic malignant melanoma in prepubertal children. Pediatrics 55:191–204, 1975.

    PubMed  CAS  Google Scholar 

  20. Quaba AA, Wallace AF: The incidence of malignant melanoma (0 to 15 years of age) arising in “large” congenital nevocellular nevi. Plastic Reconstr Surg 78:174–178, 1986.

    Article  CAS  Google Scholar 

  21. Pers M: Naevus pigmentosus giganticus: Indikationer fur operative Behandling. Ugeskr Laeger 125:613–620, 1963.

    Google Scholar 

  22. Lorentzen M, Pers M, Brettevill-Jensen G: The incidence of malignant transformation in giant pigmented nevi. Scand J Plast Reconstr Surg 11:163–167, 1977.

    Article  PubMed  CAS  Google Scholar 

  23. Rhodes AR, Wood WC, Sober AJ, et al: Non-epidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg 67:782–790, 1981.

    Article  PubMed  CAS  Google Scholar 

  24. Cristofolini M, Franceschi S, Tasin L, et al: Risk factors for cutaneous melanoma in a northern Italian population. Int J Cancer 30:150–154, 1981.

    Google Scholar 

  25. Elashoff RM, Hunter TD, Mohilef E: Final report on epidemiology of melanoma. NICHD Contract HD-8–2803, 1982.

    Google Scholar 

  26. Reynolds P, Austin DF: Epidemiologic-based screening strategies for malignant melanoma of the skin. In: Advances in cancer control: Epidemiology and research, Engstrom PF, Anderson PN, Mortenson LE (eds). New York: Alan R. Liss, 1984, pp. 245–254.

    Google Scholar 

  27. Sorahan T, Grimley RP: The etiological significance of sunlight and fluorescent lighting in malignant melanoma: A case-control study. Br J Cancer 52:765–769, 1985.

    Article  PubMed  CAS  Google Scholar 

  28. Beral V, Evans S, Shaw H, et al: Cutaneous factors related to the risk of malignant melanoma. Br J Dermatol 109:165–172, 1983.

    Article  PubMed  CAS  Google Scholar 

  29. English DR, Menz J, Heenan PJ, et al: The dysplastic nevus syndrome in patients with cutaneous malignant melanoma in Australia. Med J Austr 145(5):194–198, 1986.

    CAS  Google Scholar 

  30. Friedman RJ, Rigel DS, Kopf AW, et al: Favorable prognosis for malignant melanomas associated with acquired melanocytic nevi. Arch Dermatol 119:455–462, 1983.

    Article  PubMed  CAS  Google Scholar 

  31. Rhodes AR, Harrist TJ, Day CL, et al: Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas. J Am Acad Dermatol 9:563–574, 1983.

    Article  PubMed  CAS  Google Scholar 

  32. Clark WH Jr, Reimer RR, Greene HM, et al: Origin of familial malignant melanoma from heritable melanocytic lesions. The “BK mole syndrome.” Arch Dermatol 114:732–738, 1978.

    Article  PubMed  Google Scholar 

  33. Greene MH, Reimer RR, Clark WH Jr, et al: Precursor lesions in familial melanoma. Semin Oncol 5:85–87, 1978.

    PubMed  CAS  Google Scholar 

  34. Reimer RR, Clark WH Jr, Greene MH, et al: Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA 239:744–746, 1978.

    Article  PubMed  CAS  Google Scholar 

  35. Lynch HT, Frichot B III, Lynch JF: Familial atypical multiple-mole melanoma syndrome. J Med Genet 15:352–356, 1978.

    Article  PubMed  CAS  Google Scholar 

  36. Greene MH, Clark WH, Tucker MA, et al: High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Int Med 102:458–465, 1985.

    PubMed  CAS  Google Scholar 

  37. Ariel IM: Theories regarding the etiology of malignant melanoma. New York: Appleton-Century-Crofts, 1981, pp. 9–32.

    Google Scholar 

  38. Miller TR, Pack GT: The familial aspects of malignant melanoma. Arch Derm 86:35–38, 1962.

    PubMed  CAS  Google Scholar 

  39. Friedman RJ, Heilman ER, Rigel DS, Kopf AW: The dysplastic nevus: Clinical and pathological features. Dermatologic Clin 3:239–249, 1985.

    CAS  Google Scholar 

  40. Kraemer KH, Greene MH: Dysplastic nevus syndrome: Familial and sporadic precursors of cutaneous melanoma. Dermatologic Clin 3:225–237, 1985.

    CAS  Google Scholar 

  41. Kelly JW, Crutcher WA, Sagebiel RW: Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation. J Am Acad Dermatol 14:1044–1052, 1986.

    Article  PubMed  CAS  Google Scholar 

  42. Elder DE, Greene MH, Bondi EE, Clark WH, Jr: Chapter 11. Acquired melanocytic nevi and melanoma: The dysplastic nevus syndrome. In: Pathology of malignant melanoma, Ackerman AB (ed). New York: Masson, 1981, pp. 185–215.

    Google Scholar 

  43. Greene MH, Clark WH Jr, Tucker MA, et al: Current concepts: Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med 312:91–97, 1985.

    Article  PubMed  CAS  Google Scholar 

  44. Roush GC, Titus LJ, Ernstoff MS, et al: Prediction of histologically dysplastic melanocytic nevi from clinical and epidemiologic information. Clin Res 34:418A, 1986.

    Google Scholar 

  45. National Institutes of Health Consensus Panel: Precursors to malignant melanoma. J Am Acad Derm 10:683–687, 1984.

    Article  Google Scholar 

  46. Ackerman AB: Critical commentary on statements in “precursors to malignant melanoma.” Am J Dermatopath 6:181–183, 1984.

    PubMed  Google Scholar 

  47. Ackerman AB, Mihara I: Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanoma. Hum Pathol 16:87–91, 1985.

    Article  PubMed  CAS  Google Scholar 

  48. Greene MH, Goldin LR, Clark WH Jr, et al: Familial cutaneous malignant melanoma: Autosomal dominant trait possibly linked to Rh locus. Proc Natl Acad Sci 80:6071–6075, 1983.

    Article  PubMed  CAS  Google Scholar 

  49. Roush GC, Barnhill RL, Duray PH, et al: Diagnosis of the dysplastic nevus in different populations. J Am Acad Dermatol 14:419–425, 1986.

    Article  PubMed  CAS  Google Scholar 

  50. McGee D, Reed D, Yano K: The results of logistic analyses when the variables are highly correlated: An empirical example using diet and CHD incidence. J Chron Dis 37:713–719, 1984.

    Article  PubMed  CAS  Google Scholar 

  51. Gordon T: Editorial: Hazards in the use of the logistic function with special reference to data from prospective cardiovascular studies. J Chron Dis 27:97–102, 1974.

    Article  PubMed  CAS  Google Scholar 

  52. Rhodes AR, Melslei JW, Sober AJ, et al: Increased intraepidermal melanocytic frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellalar nevi, and solar lentigines. J Invest Dermatol 80:452–459, 1983.

    Article  PubMed  CAS  Google Scholar 

  53. Greene MH, Young TI, Clark WH: Malignant melanoma in renal-transplant recipients. Lancet 1:1196–1199, 1981.

    Article  PubMed  CAS  Google Scholar 

  54. Tucker MA, Misfeldt D, Coleman N, et al: Cutaneous malignant melanoma after Hodg-kin’s disease. Ann Intern Med 102:37–41, 1985.

    PubMed  CAS  Google Scholar 

  55. Sagebiel RW, Banda PW, Schneider JS, Crutcher WA. Age distribution and histologic patterns of dysplastic nevi. J Am Acad Derm 13:975–982, 1985.

    Article  PubMed  CAS  Google Scholar 

  56. Clark WH Jr, Elder DE, Guerry D IV, et al: A study of tumor progression: The precursor lesions of superficial spreading and nodular melanoma. Human Pathol 15:1147–1165, 1984.

    Article  Google Scholar 

  57. Lynch HT, Fusaro RM, Pester J, et al: Familial atypical multiple mole melanoma (FAMM) syndrome: Genetic heterogeneity and malignant melanoma. Br J Cancer 42:58–70, 1980.

    Article  PubMed  CAS  Google Scholar 

  58. Paul E: Growth dynamics of MM: A photodocumentary investigation. Arch Dermatol 116:182–185, 1980.

    Article  PubMed  CAS  Google Scholar 

  59. Paul E: Entstehung maligner melanoma auf praexisten pigmentlasionen. Uberprufing der anamnestischen angaben anhand von privaten photoserien der patienten. Der Hautartz 28:638–647, 1977.

    CAS  Google Scholar 

  60. Pack GT, Davis T: The pigmented mole. Postgrad Med 27:370–382, 1960.

    PubMed  CAS  Google Scholar 

  61. Rippey JJ, Whiting DA: Moles and melanomas (letter). Lancet 2:137, 1977.

    Article  PubMed  CAS  Google Scholar 

  62. Kelly JW, Crutcher WA, Sagebiel RW: Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation. J Am Acad Deramtol 14:1044–1052, 1986.

    Article  CAS  Google Scholar 

  63. Roush GC, Kirkwood JM, Ernstoff MS, et al: Reproducibility and validity in the clinical diagnosis of the non-familial dysplastic nevus: Work in progress. Recent Results in Cancer Res 102:154–159, 1986.

    CAS  Google Scholar 

  64. Maize JC, Foster G: Age-related changes in melanocytic nevi. Clinical and Exp Dermatol 4:49–58, 1979.

    Article  CAS  Google Scholar 

  65. Cooke KR, Spears GFS, Skegg DCG: Frequency of moles in a defined population. J Epid Comm Health 39:48–52, 1985.

    Article  CAS  Google Scholar 

  66. Mackie RM, English J, Aitchison TC, et al: The number and distribution of benign pigmented moles (melanocytic nevi) in a healthy British population. Br J Dermatol 113:167–174, 1985.

    Article  PubMed  CAS  Google Scholar 

  67. Kopf AW, Lazar M, Bart RS, et al: Prevalence of nevocytic nevi on the lateral and medal aspects of the arms. J Dermatol Surg Oncol 4:153–158, 1978.

    PubMed  CAS  Google Scholar 

  68. Kopf AW, Lindsay AC, Rogers GS, et al: Relationship of nevocytic nevi to sun exposure in dysplastic nevus syndrome. J Am Acad Derm 12:656–662, 1985.

    Article  PubMed  CAS  Google Scholar 

  69. Rampen FHJ, van der Meeren HLM, Boezeman JBM: Frequency of moles as a key to melanoma incidence. J Am Acad Derm 15:1200–1203, 1986.

    Article  PubMed  CAS  Google Scholar 

  70. Pack GT, Lenson N, Gerber DM: Regional distribution of moles and melanoma. AMA Arch Surg 65:862–870, 1952.

    PubMed  CAS  Google Scholar 

  71. Holman CDJ, Armstrong BK: Cutaneous malignant melanoma and indicators of total cumulated sun exposure to the sun: An analysis separating histogenetic types. J Natl Cancer Inst 73:75–82, 1984.

    PubMed  CAS  Google Scholar 

  72. Roush GC, Holford TR, Schymura MJ, et al: Cancer risk and incidence trends: The Connecticut perspective. New York: Harper & Row, 1987.

    Google Scholar 

  73. Holman CDJ, Heenan PJ, Caruso V, et al: Seasonal variation in the junctional component of pigmented naevi. Int J Cancer 31:213–215, 1983.

    Article  PubMed  CAS  Google Scholar 

  74. Rhodes AR: Acquired dysplastic melanocytic nevi and cutaneous melanoma: Precursors and prevention. Ann Int Med 102:546–547, 1985.

    PubMed  CAS  Google Scholar 

  75. Roush GC, Schymura MJ, Holford TR: Risk for cutaneous melanoma in recent birth cohorts. Am J Publ Hlth 75:679–682, 1985.

    Article  CAS  Google Scholar 

  76. Mihm MC, Fitzpatrick TB, Brown MML, et al: Early detection of primary cutaneous melanoma. A color atlas. N Engl J Med 289:989–996, 1973.

    Article  PubMed  Google Scholar 

  77. Friedman RJ, Rigel DS, Kopf AW: Early detection of malignant melanoma: The role of physician examination and self-examination of the skin. CA 35:130–151, 1985.

    PubMed  CAS  Google Scholar 

  78. Sober AJ, Day CL, Kopf AW, et al: Detection of “thin” primary melanomas. CA 33: 160–163, 1983.

    PubMed  CAS  Google Scholar 

  79. Ackerman AB: Editorial: No one should die of malignant melanoma. Am J Dermatol 12:115–116, 1985.

    CAS  Google Scholar 

  80. Greene MH: Dysplastic nevus syndrome. Hosp Pract 20:91–108, 1984.

    Google Scholar 

  81. Kraemer KH, Greene MH, Tarone R, et al: Dysplastic naevi and cutaneous melanoma risk (letter). Lancet 2:1076–1077, 1983.

    Article  PubMed  CAS  Google Scholar 

  82. Gruber SB, Roush GC, Barnhill RL: Screening for individuals at high risk for malignant melanoma by self-examination and dermatologic follow-up. Clinical Research 34:886A, 1986.

    Google Scholar 

Download references

Authors
  1. George C. Roush
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Winthrop-University Hospital, Mineola, New York, USA

    Larry Nathanson

  2. Department of Medicine, Health Science Center, SUNY, Stony Brook, New York, USA

    Larry Nathanson

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Kluwer Academic Publishers, Boston

About this chapter

Cite this chapter

Roush, G.C. (1988). Abnormal nevi, excess total nevi, and melanoma: an epidemiologic perspective. In: Nathanson, L. (eds) Malignant Melanoma: Biology, Diagnosis, and Therapy. Cancer Treatment and Research, vol 43. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1751-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1751-7_6

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8983-8

  • Online ISBN: 978-1-4613-1751-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation